Achieve Life Sciences, Inc. (QUIT)
Snapshot
- 1 week
- -6.0%-8.5% vs SPY
- 1 month
- -9.7%-6.7% vs SPY
- Market cap
- $650.3M
- P/E
- negindustry 52.3
- P/B
- 3.7
- EV/EBITDA
- -5.4
- FCF yield
- -6.8%
- Consensus
- Buy6 buy · 0 hold · 0 sell
- Price target
- $15.25+141.3% upside
Signal evidence
Prediction markets
… linked markets on Kalshi and Polymarket.
Company
Healthcare · Medical - Pharmaceuticals · CEO Andrew D. Goldberg
Achieve Life Sciences, Inc. (QUIT). Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
- Andrew D. GoldbergCEO, President & Director
- Erik AtkissonChief Legal OfficerUSD 521K
- Benjamin HalladayChief Financial OfficerUSD 425K
- Mark K. OkiChief Financial OfficerUSD 425K
- Mark L. RubinsteinChief Medical Officer
- Jerry WanVice President of Finance & Principal Accounting Officer
Snapshot
Price & returns1 month -9.7%
- 1 week
- -6.0%-8.5% vs SPY
- 1 month
- -9.7%-6.7% vs SPY
ValuationP/E neg vs industry 52.3 · market cap $650.3M
- Market cap
- $650.3M
- P/E
- negindustry 52.3
- P/B
- 3.7
- EV/EBITDA
- -5.4
- FCF yield
- -6.8%
Street & earningsTarget $15.25 (+141.3% upside)6 buy · 0 hold · 0 sell
- Consensus
- Buy6 buy · 0 hold · 0 sell
- Price target
- $15.25+141.3% upside
Signal evidence
Prediction markets
… linked markets on Kalshi and Polymarket.
Company
Healthcare · Medical - Pharmaceuticals · CEO Andrew D. Goldberg
Achieve Life Sciences, Inc. (QUIT). Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.
- Andrew D. GoldbergCEO, President & Director
- Erik AtkissonChief Legal OfficerUSD 521K
- Benjamin HalladayChief Financial OfficerUSD 425K
- Mark K. OkiChief Financial OfficerUSD 425K
Company news
Congress trades
STOCK Act filings